BioFluidica

Are you attending #TRICON next week? Catch up with us in San Francisco's Moscone Convention Center and learn about BioFluidica's Microfluidic Chip Technology. https://www.biofluidica.com/index.html

Join us this year at the upcoming 2019 CED Life Science Conference where we will join together with a list of 70 featured companies in the #TriangleLifeScience community on February 26-27 in Raleigh for the most innovative entrepreneurial event of the year. Register Now: https://bit.ly/2GTNPDJ View the full list of featured companies https://bit.ly/2Jz9Rt9

Catch Rolf Muller's Tech Showcase Knobbe Martens for MIT Enterprise Forum of San Diego tonight @5:30PM. Register here for Hope for Millions: BioFluidica revolutionizes cancer diagnostics: http://mitefsd.org/event/2019_feb_20/

Dr. Steven Soper, KU Foundation Distinguished Professor of Chemistry and Mechanical Engineering and BioFluidica's Chief Technology Officer, and Director of the National Institutes of Health (NIH)/NIBIB-funded Center of BioModular Multi-scale Systems for Precision Medicine, will be featured on this week’s University of Kansas Cancer Center Facebook Live: Bench to Bedside discussion Detecting Undetectable Cancers on Wednesday, February 20 at 10:00(CT).

Excited to have CEO, Rolf Muller, present at MarketsandMarkets Biomarker and Companion Diagnostics Conference at the Westin San Diego Gaslamp Quarter. Presenting on Day 1, February 7th, on BioFluidica's High-Specificity and High-Throughput liquid biopsy Technology for Non-Invasive Cancer and Prenatal Diagnostics http://events.marketsandmarkets.com/4th-Annual-Biomarker-an

Great article by GenomeWeb on how BioFluidica's Liquid Scan is improving prenatal testing and early detection of relapse patients. https://www.biofluidica.com//BioFluidica%20Applying%20Liqu

We have been awarded two National Institutes of Health (NIH) and National Cancer Institute grants for our work in Isolation of Cell-Free DNA and Exosomes on Its Single Liquid Biopsy Platform. #biotech #nih #cfDNA https://www.prnewswire.com//san-diego-blood-chip-maker-bio

Are you attending Precision Medicine World Conference - PMWC LLC next week? Catch BioFluidica's CEO, Rolf Muller present on hashtag#liquidbiopsy on Jan. 21st 1:00PM on track5 and learn more about Biofluidica's diagnostic platform is able to precisely capture and isolate disease biomarkers. #biotechnology #biomarker #pmwc #CTCs https://www.pmwcintl.com/rolf-muller-2019sv/

https://marketresearchreport24.wordpress.com//circulating/ Read about how BioFluidica is developing technology for detecting Circulating Tumor Cells (CTC). CTC tests possess the ability to quantify, detect, and analyze tumor cells inside a patient’s blood.

Check out The San Diego Union-Tribune article featuring CEO Rolf Muller discuss BioFluidica's Liquid Scan Technology http://www.sandiegouniontribune.com//sd-me-biofluidica-201